INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 410m ago
HOUSE PTR10m ago
SEC 13F10m ago
ROBINHOOD CHAIN10m ago
Corporate insider
MD

McCombe William D.

Chief Financial OfficerCIK 0001878824

EDGAR filingsOpen in network
Disclosed transactions24
Buys / sells0 / 0
Max Insider Score13
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
MD
McCombe William D.Chief Financial Officer
CTKBCytek Biosciences, Inc.
Tax withholding
F$21K
4,392 sh
Aug 18, 2026Aug 20, 2026
traded Aug 18, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Cytek Biosciences, Inc.Chief Financial Officer · Nov 20, 2025
13
MD
McCombe William D.Chief Financial Officer
CTKBCytek Biosciences, Inc.
Option exercise
M
—
13.1K sh
Aug 18, 2026
Aug 20, 2026
traded Aug 18, 2026
+2d
SEC FORM 4

Evidence

13
MD
McCombe William D.Chief Financial Officer
CTKBCytek Biosciences, Inc.
Option exercise
M—
16.0K sh
Aug 18, 2026Aug 20, 2026
traded Aug 18, 2026
+2dSEC FORM 4

Evidence

9
MD
McCombe William D.Chief Financial Officer
CTKBCytek Biosciences, Inc.
Tax withholding
F$25K
5,401 sh
Aug 18, 2026Aug 20, 2026
traded Aug 18, 2026
+2dSEC FORM 4

Evidence

13
MD
McCombe William D.Chief Financial Officer
CTKBCytek Biosciences, Inc.
Option exercise
M—
13.1K sh
Aug 18, 2026Aug 20, 2026
traded Aug 18, 2026
+2dSEC FORM 4

Evidence

13
MD
McCombe William D.Chief Financial Officer
CTKBCytek Biosciences, Inc.
Option exercise
M—
16.0K sh
Aug 18, 2026Aug 20, 2026
traded Aug 18, 2026
+2dSEC FORM 4

Evidence

13
MD
McCombe William D.Chief Financial Officer
CTKBCytek Biosciences, Inc.
Option exercise
M—
6,320 sh
Aug 18, 2026Aug 20, 2026
traded Aug 18, 2026
+2dSEC FORM 4

Evidence

9
MD
McCombe William D.Chief Financial Officer
CTKBCytek Biosciences, Inc.
Tax withholding
F$9,858
2,111 sh
Aug 18, 2026Aug 20, 2026
traded Aug 18, 2026
+2dSEC FORM 4

Evidence

13
MD
McCombe William D.Chief Financial Officer
CTKBCytek Biosciences, Inc.
Option exercise
M—
6,320 sh
Aug 18, 2026Aug 20, 2026
traded Aug 18, 2026
+2dSEC FORM 4

Evidence

9
MD
McCombe William D.Chief Financial Officer
CTKBCytek Biosciences, Inc.
Tax withholding
F$11K
3,122 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC FORM 4

Evidence

9
MD
McCombe William D.Chief Financial Officer
CTKBCytek Biosciences, Inc.
Tax withholding
F$14K
3,839 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC FORM 4

Evidence

13
MD
McCombe William D.Chief Financial Officer
CTKBCytek Biosciences, Inc.
Option exercise
M—
6,320 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC FORM 4

Evidence

13
MD
McCombe William D.Chief Financial Officer
CTKBCytek Biosciences, Inc.
Option exercise
M—
8,700 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC FORM 4

Evidence

9
MD
McCombe William D.Chief Financial Officer
CTKBCytek Biosciences, Inc.
Option exercise
M—
10.7K sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC FORM 4

Evidence

13
MD
McCombe William D.Chief Financial Officer
CTKBCytek Biosciences, Inc.
Option exercise
M—
10.7K sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC FORM 4

Evidence

13
MD
McCombe William D.Chief Financial Officer
CTKBCytek Biosciences, Inc.
Option exercise
M—
6,320 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC FORM 4

Evidence

9
MD
McCombe William D.Chief Financial Officer
CTKBCytek Biosciences, Inc.
Tax withholding
F$8,051
2,268 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC FORM 4

Evidence

13
MD
McCombe William D.Chief Financial Officer
CTKBCytek Biosciences, Inc.
Option exercise
M—
8,700 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC FORM 4

Evidence

13
MD
McCombe William D.Chief Financial Officer
CTKBCytek Biosciences, Inc.
Option exercise
M—
13.1K sh
Nov 18, 2025Nov 20, 2025
traded Nov 18, 2025
+2dSEC FORM 4

Evidence

9
MD
McCombe William D.Chief Financial Officer
CTKBCytek Biosciences, Inc.
Tax withholding
F$11K
2,032 sh
Nov 18, 2025Nov 20, 2025
traded Nov 18, 2025
+2dSEC FORM 4

Evidence

13
MD
McCombe William D.Chief Financial Officer
CTKBCytek Biosciences, Inc.
Option exercise
M—
6,320 sh
Nov 18, 2025Nov 20, 2025
traded Nov 18, 2025
+2dSEC FORM 4

Evidence

13
MD
McCombe William D.Chief Financial Officer
CTKBCytek Biosciences, Inc.
Option exercise
M—
13.1K sh
Nov 18, 2025Nov 20, 2025
traded Nov 18, 2025
+2dSEC FORM 4

Evidence

13
MD
McCombe William D.Chief Financial Officer
CTKBCytek Biosciences, Inc.
Tax withholding
F$23K
4,196 sh
Nov 18, 2025Nov 20, 2025
traded Nov 18, 2025
+2dSEC FORM 4

Evidence

13
MD
McCombe William D.Chief Financial Officer
CTKBCytek Biosciences, Inc.
Option exercise
M—
6,320 sh
Nov 18, 2025Nov 20, 2025
traded Nov 18, 2025
+2dSEC FORM 4

Evidence